Joseph Barnett YOU? Author Swipe

Last 10y

A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema Open

Athol U. Wells, Joseph Jacob, Nicola Sverzellati, Gary Cross, Joseph Barnett , et al. · 2024

Background No single pulmonary function test captures the functional effect of emphysema in idiopathic pulmonary fibrosis (IPF). Without experienced radiologists, other methods are needed to determine emphysema extent. Here, we report the …

High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study Open

Sujal R. Desai, Nishanth Sivarasan, Kerri A. Johannson, Peter M. George, Daniel A. Culver , et al. · 2023

Mortality surrogates in combined pulmonary fibrosis and emphysema Open

An Zhao, Eyjólfur Gudmundsson, Nesrin Moğulkoç, Coline van Moorsel, Tamera J. Corte , et al. · 2023

Background Idiopathic pulmonary fibrosis (IPF) with coexistent emphysema, termed combined pulmonary fibrosis and emphysema (CPFE) may associate with reduced forced vital capacity (FVC) declines compared to non-CPFE IPF patients. We examine…

Radiomics-based decision support tool assists radiologists in small lung nodule classification and improves lung cancer early diagnosis Open

Benjamin Hunter, Christos Argyros, Marianna Inglese, Kristofer Linton‐Reid, Ilaria Pulzato , et al. · 2023

Cross-sectional study evaluating the impact of SARS-CoV-2 variants on Long COVID outcomes in UK hospital survivors Open

Anita Saigal, Camila Nagoda Niklewicz, SB Naidu, Heba M Bintalib, Amar Jitu Shah , et al. · 2023

Objectives COVID-19 studies report on hospital admission outcomes across SARS-CoV-2 waves of infection but knowledge of the impact of SARS-CoV-2 variants on the development of Long COVID in hospital survivors is limited. We sought to inves…

Mortality surrogates in combined pulmonary fibrosis and emphysema Open

An Zhao, Eyjólfur Gudmundsson, Nesrin Moğulkoç, Coline van Moorsel, Tamera J. Corte , et al. · 2023

Background Idiopathic pulmonary fibrosis (IPF) with co-existent emphysema, termed combined pulmonary fibrosis and emphysema (CPFE) may be associated with reduced FVC decline compared to non-CPFE IPF patients. We examined associations betwe…

P157 Distinct differences in complement perturbation between scleroderma-related interstitial lung disease with and without emphysema Open

Claire Beesley, Alice Cole, Nina Goldman, Joseph Barnett, David Abraham , et al. · 2023

Background/Aims Aberrant complement activation is associated with autoimmune diseases including systemic sclerosis (SSc). As a leading cause of death in SSc, interstitial lung disease (ILD) can coexist with emphysema in non-smoking patient…

Automated quantification system predicts survival in rheumatoid arthritis-associated interstitial lung disease Open

Ju Hyun Oh, Grace Hyun J. Kim, Gary Cross, Joseph Barnett, Joseph Jacob , et al. · 2022

Objective The prognosis of RA-associated interstitial lung disease (RA-ILD) is difficult to predict because of the variable clinical course. This study aimed to determine the prognostic value of an automated quantification system (AQS) in …

P97 Disease severity and patient recovery in COVID-19: an observational study comparing first and second wave admissions in London Open

Anita Saigal, CN Niklewicz, SB Naidu, HM Bintalib, AJ Shah , et al. · 2021

Background The COVID-19 global pandemic presents with waves of infection. International studies report key demographic and outcome differences with younger patients, lower co-morbidity and mortality reported amongst second wave patients.

S58 The impact of smoking on symptom and radiological severity at COVID-19 follow up Open

AJ Shah, Anita Saigal, SB Naidu, Simon Brill, Hannah Jarvis , et al. · 2021

Background The relationship between smoking and COVID-19 disease severity is uncertain; one meta-analysis found smoking increases the risk of developing severe COVID-19 two-fold.¹ No previous study has reported whether smokers h…

P9 Do persistent chest radiograph changes correlate with ongoing respiratory symptoms in patients recovering from COVID-19 pneumonia? Open

NG Jain, Anita Saigal, SB Naidu, AJ Shah, SE Brill , et al. · 2021

Introduction and Objectives In May 2020, BTS published guidelines on radiological follow-up for patients with COVID-19 pneumonia, advising an initial repeat chest radiograph at 12 weeks to assess resolution.¹ It is unclear wheth…

‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 Open

Swapna Mandal, Joseph Barnett, Simon Brill, Jeremy Brown, Emma Denneny , et al. · 2020

Large numbers of people are being discharged from hospital following COVID-19 without assessment of recovery. In 384 patients (mean age 59.9 years; 62% male) followed a median 54 days post discharge, 53% reported persistent breathlessness,…

The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis Open

Rachele Invernizzi, Benjamin G. Wu, Joseph Barnett, Poonam Ghai, Shaun Kingston , et al. · 2020

Rationale: Chronic hypersensitivity pneumonitis (CHP) is a condition that arises after repeated exposure and sensitization to inhaled antigens. The lung microbiome is increasingly implicated in respiratory disease, but, to date, no …

Validation of the British Society of Thoracic Imaging guidelines for COVID-19 chest radiograph reporting Open

Samanjit S Hare, Aniket Tavare, Vidhi Dattani, Besma Musaddaq, I. Beal , et al. · 2020

Risk prediction model in rheumatoid arthritis‐associated interstitial lung disease Open

Ho Cheol Kim, Jeong Seok Lee, Eun Young Lee, You‐Jung Ha, Eun Jin Chae , et al. · 2020

Background and objective RA‐ILD has a variable clinical course, and its prognosis is difficult to predict. Moreover, risk prediction models for prognosis remain undefined. Methods The prediction model was developed using retrospective data…

Serial CT analysis in idiopathic pulmonary fibrosis: comparison of visual features that determine patient outcome Open

Joseph Jacob, Leon Aksman, Nesrin Moğulkoç, Alex Procter, Bahareh Gholipour , et al. · 2020

Aims Patients with idiopathic pulmonary fibrosis (IPF) receiving antifibrotic medication and patients with non-IPF fibrosing lung disease often demonstrate rates of annualised forced vital capacity (FVC) decline within the range of measure…

Managing high clinical suspicion COVID-19 inpatients with negative RT-PCR: a pragmatic and limited role for thoracic CT Open

Aniket Tavare, Aaron Braddy-Green, Simon Brill, Hannah Jarvis, Anand Sivaramakrishnan , et al. · 2020

As the COVID-19 pandemic sweeps across the UK there remain issues with reverse-transcription polymerase chain reaction (RT-PCR), the gold standard diagnostic method. Delays in obtaining results have been particularly problematic. Some pati…

Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent Open

Rachele Invernizzi, Joseph Barnett, Bhavin Rawal, Arjun Nair, Poonam Ghai , et al. · 2020

Increasing bacterial burden in the lower airways of patients with idiopathic pulmonary fibrosis confers an increased risk of disease progression and mortality. However, it remains unclear whether this increased bacterial burden directly in…

Diffuse alveoläre Hämorrhagie mit späterer ANCA-Positivität und Emphysembildung bei drei jungen Erwachsenen Open

Anna Stainer, Alex Rice, Anand Devaraj, Joseph Barnett, Jacqueline Donovan , et al. · 2020

Hintergrund: Die diffuse alveoläre Hämorrhagie (DAH) ist durch die diffuse Anreicherung von roten Blutkörperchen in den Alveolen und durch Milchglastrübungen und/oder Konsolidierungen in der Computertomographie (CT) gekennzeichnet. Wenn ke…

Veranstaltungskalender Open